A phase II study of erlotinib plus capecitabine (XEL) as first-line treatment for elderly patients (pts) with advanced adenocarcinoma of lung (ML 22206 study). Background: Detecting epidermal growth ...
Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer: A phase II, open-label, multicenter, randomized study. This is an ASCO Meeting Abstract from the 2013 ...
New research led by the Seaver Autism Center for Research and Treatment at Mount Sinai has illuminated genetic differences among children with a rare neurodevelopmental condition and could point the ...
Objective: Jaundice is a common disorder in neonates and G6PD deficiency could result in kernicterus. The aim of This study was to compare of G6PD mutation in icteric and non icteric neonates. Methods ...
Researchers have created the first complete map showing how hundreds of mutations in a key cancer gene affect tumor growth. By testing every possible mutation in a critical hotspot, they found that ...
Synonymous mutations have long been ignored in cancer studies since they don’t affect the amino acid sequences of proteins. But research increasingly reveals that they can have disease-driving effects ...
Several genes within the body can mutate and lead to non-small cell lung cancer (NSCLC). The genes that these mutations can occur with include epidermal growth factor receptor (EGFR), TP53, and KRAS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results